SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2831)5/13/2010 12:26:08 PM
From: Jibacoa  Respond to of 3722
 
MBCI seems to have found support at the $0.30 level.<g>

The stock up 16.67% on low volume, about 1/3 of its ADV.

bigcharts.marketwatch.com

Back in March it had a private placement for $1M <g>

finance.yahoo.com

MBCI is trying to create highly specific monoclonal antibodies which will be developed as diagnostic tools,imaging agents and drugs to treat Cas.
Its initial goal is to develop MAbs as diagnostic tools for the detection of ovarian and prostate Cas at an early stage.<g>
mabcure.com.

With some good news the stock could get to test the resistance at the $0.50 level.<g>

bigcharts.marketwatch.com

Bernard